How human cerebral organoids are transforming epilepsy modeling and drug discovery
2 Mar 2026
Explore the innovative use of human cerebral organoids to model epilepsy and discover novel anti-seizure medications. Dr. Robert Halliwell, University of the Pacific, details how these 3D neural circuits, derived from stem cells, exhibit functional activity and can be used to test drug efficacy. He also highlights the potential of organoids to overcome limitations of traditional models in developing treatments for neurological disorders.
About the company
Axion BioSystems
Axion BioSystems empowers scientists to reach new heights of discovery with innovative, user-friendly lab tools that deliver powerful live-cell analysis for disease research, therapeutic development, and applied industries. Designed for continuous, noninvasive monitoring of 2D and 3D in vitro cell models from the benchtop or incubator, Axion’s next-generation systems are indispensable tools in academic, biotechnology, and pharmaceutical labs worldwide.
Since launching the revolutionary Maestro MEA (microelectrode array) platform more than 15 years ago, Axion has continuously expanded its offerings to meet the demands of today’s complex research, first with the impedance-based Maestro Z live-cell analyzer and then the easy-to-use Omni live-cell imager. Featuring intuitive controls, powerful software, and flexible throughput, Axion’s state-of-the-art systems are available for a range of applications and budgets.
